MedTrace Logo

Safety and Effectiveness of the Coronary Momo Stent

NCT01535625 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-02-20

No results posted yet for this study

Summary

This study evaluates the safety and effectiveness of the Momo Cobalt Chromium stent system for the treatment of single de novo lesions in a native coronary artery. The stent is coated with diamond-like carbon to decrease the risk of acute and late stent thrombosis, to increase the resistance towards corrosion and to significantly improve endothelialisation through the inhibition of elution of metallic ions.

Conditions

Interventions

DEVICE

Momo stent

Patients with PCI

Sponsors & Collaborators

  • Japan Stent Technology Europe GmbH

    collaborator INDUSTRY

  • be Medical

    lead INDUSTRY

Principal Investigators

  • Luc Janssens, MD · Imelda vzw

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-01-31
Completion
2013-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01535625 on ClinicalTrials.gov